Citations

Mayo Clinic

Showing 10 of 108522 citations.

Appendiceal intussusception due to endometriosis presenting as acute right lower quadrant pain
Sadaney, Ahmed O El , Sandhu, Ariel D, Parvinian, Ahmad , Nehra, Avinash , Suman, Garima , O El Sadaney, Ahmed, El Sadaney, Ahmed O

BJR|Case Reports | September 5, 2024 | Volume: 10 | Issue: 5 | Pages: No page available

10.1093/bjrcr/uaae032 | PMID 39263000 Get It

Abstract Appendiceal intussusception is a rare condition characterized by the telescoping or invagination of a portion or the entire appendix into the caecum or within the appendix itself. Diagnosing appendiceal intussusception can be challenging due to its rarity, non-specific symptoms, and lack of awareness among physicians. We present a case report of appendiceal intussusception caused by endometriosis presenting with recurrent abdominal pain in a young female that was initially missed on CT scan and laparoscopy and eventually diagnosed on CT enterography.
Multiligament knee injury (MLKI): an expert consensus statement on nomenclature, diagnosis, treatment and rehabilitation
Murray, Iain R. , Makaram, Navnit S. , Moatshe, Gilbert , Crossley, Kay M. , Davis, Aileen M. , Tuca, María , Eun, SeungPyo, Noyes, Frank R. , Marx, Robert G. , Harner, Chris, Levy, Bruce A. , Whelan, Daniel B. , Hatch, George F. Rick , Wahl, Christopher J. , Thorborg, Kristian , Irrgang, James J. , MacDonald, Peter , Shelbourne, K. Donald , Musahl, Volker , Miller, Mark D., LaPrade, Robert F. , Murray, Iain Robert , Moatshe, Gilbert , Crossley, Kay , Davis, Aileen , Janse van Rensburg, Dina C , Emery, Carolyn A , King, Enda , Engebretsen, Lars , Seil, Romain , Verhagen, Evert , Irrgang, James J , LaPrade, Robert F , Geeslin, Andrew G. , Chahla, Jorge , Kew, Michelle Elizabeth , Potter, Hollis G. , Emery, Carolyn A. , Eun, Seung-Pyo, Grindem, Hege , Cook, James L. , Pujol, Nicolas , Medvecky, Michael J. , Stuart, Michael J. , Krych, Aaron J. , Engebretsen, Lars , Stannard, James P. , Seil, Romain , Fanelli, Gregory C. , Maak, Travis G. , Verhagen, Evert , Hirschmann, Michael T. , Schenck, Robert C.

British Journal of Sports Medicine | September 5, 2024 | Volume: 58 | Issue: 23 | Pages: 1385-1400

10.1136/bjsports-2024-108089 | PMID 39237264 Get It

Multiligament knee injuries (MLKIs) represent a broad spectrum of pathology with potentially devastating consequences. Currently, disagreement in the terminology, diagnosis and treatment of these injuries limits clinical care and research. This study aimed to develop consensus on the nomenclature, diagnosis, treatment and rehabilitation strategies for patients with MLKI, while identifying important research priorities for further study. An international consensus process was conducted using validated Delphi methodology in line with British Journal of Sports Medicine guidelines. A multidisciplinary panel of 39 members from 14 countries, completed 3 rounds of online surveys exploring aspects of nomenclature, diagnosis, treatment, rehabilitation and future research priorities. Levels of agreement (LoA) with each statement were rated anonymously on a 5-point Likert scale, with experts encouraged to suggest modifications or additional statements. LoA for consensus in the final round were defined ‘a priori’ if >75% of respondents agreed and fewer than 10% disagreed, and dissenting viewpoints were recorded and discussed. After three Delphi rounds, 50 items (92.6%) reached consensus. Key statements that reached consensus within nomenclature included a clear definition for MLKI (LoA 97.4%) and the need for an updated MLKI classification system that classifies injury mechanism, extent of non-ligamentous structures injured and the presence or absence of dislocation. Within diagnosis, consensus was reached that there should be a low threshold for assessment with CT angiography for MLKI within a high-energy context and for certain injury patterns including bicruciate and PLC injuries (LoA 89.7%). The value of stress radiography or intraoperative fluoroscopy also reached consensus (LoA 89.7%). Within treatment, it was generally agreed that existing literature generally favours operative management of MLKI, particularly for young patients (LoA 100%), and that single-stage surgery should be performed whenever possible (LoA 92.3%). This consensus statement will facilitate clinical communication in MLKI, the care of these patients and future research within MLKI.
Evaluating the Impact of Robotic Ileal Pouch-anal Anastomosis
Violante, Tommaso , Novelli, Marco , Perry, William , Mathis, Kellie L. , Dozois, Eric J. , Merchea, Amit , Shawki, Sherief S., Perry, William R., Violante, Tommaso , Perry, William R , Ferrari, Davide , Behm, Kevin T. , Shawki, Sherief , Larson, David W.

Annals of Surgery | September 5, 2024 | Volume: 283 | Issue: 3 | Pages: 513-518

10.1097/sla.0000000000006524 | PMID 39234747 Get It

Objective: To compare robotic-assisted proctectomy with ileal pouch-anal anastomosis (R-IPAA) outcomes and laparoscopic proctectomy with IPAA within a specialized robotic surgery center, using matching techniques to minimize potential confounding factors. Background: Minimally invasive approaches, particularly laparoscopy, have improved outcomes for patients with inflammatory bowel disease and familial adenomatous polyposis undergoing IPAA. Robotic-assisted surgery offers potential technical advantages, but its definitive superiority over laparoscopy in this context remains under debate. Methods: This retrospective, “Strengthening the Reporting of Observational Studies in Epidemiology”–compliant study analyzed 234 consecutive patients undergoing IPAA (117 robotic and 117 laparoscopic). Data encompassed patient demographics, intraoperative details, and postoperative outcomes. We employed various matching techniques to address potential bias. Primary endpoints focused on 30-day complications, readmissions, and reoperations, with secondary endpoints including hospital stay, blood loss, and stoma closure rates. Results: R-IPAA demonstrated a lower conversion rate to open surgery ( P = 0.02), a shorter hospital stay ( P = 0.04), and reduced blood loss ( P = 0.0003) compared with laparoscopic proctectomy with IPAA. While overall 30-day morbidity rates were similar ( P = 0.4), matched analyses suggested a trend towards fewer reoperations and 3-month IPAA-associated complications after diverting loop ileostomy closure in the robotic group. However, these differences did not reach statistical significance. Conclusions: In a high-volume robotic surgery center, R-IPAA reduced the risk of conversion to open surgery while reducing intraoperative blood loss and providing shorter lengths of stay with equivalent perioperative outcomes. Promising trends to reduce 30-day reoperations and surgical complications after diverting loop ileostomy closure were observed after a matching analysis.
Surgical Repair of Tetralogy of Fallot Using Autologous Right Atrial Appendage to Reconstruct the Right Ventricular Outflow Tract: A Case Series With Four-Year Follow-up
Egunov, O.A. , Cetta, Frank , Egunov, Oleg A , Kozhanov, R.S. , Кривощеков, Е. В.

World Journal for Pediatric and Congenital Heart Surgery | September 5, 2024 | Volume: 15 | Issue: 6 | Pages: 861-863

10.1177/21501351241269945 | PMID 39234675 Get It

This clinical case series describes the surgical management of tetralogy of Fallot in five children using autologous right atrial appendage to reconstruct the right ventricular outflow tract. Transthoracic echocardiography performed at four-year follow-up showed a mild residual gradient and moderate regurgitation of the neopulmonary valve in all cases.
Financial Toxicity of Long‐Term Survivors Who Underwent Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma
Muaddi, Hala , Zironda, Andrea , Zhang, Chi , Day, Courtney N. , Warner, Susanne G, Smoot, Rory L., Kendrick, Michael L. , Truty, Mark J. , Smoot, Rory L. , Smoot, Rory L , Starlinger, Patrick , Warner, Susanne G. , Cleary, Sean P. , Thiels, Cornelius A.

Journal of Surgical Oncology | September 5, 2024 | Volume: 131 | Issue: 2 | Pages: 232-241

10.1002/jso.27871 | PMID 39233671 Get It

ABSTRACT Background Pancreatoduodenectomy (PD) for pancreatic cancer has a profound impact on patients' lives. However, the long‐term financial implications are poorly understood. Objective Assess the financial burden of long‐term survivors who underwent PD. Methods Patients who underwent PD between January 2011 and June 2019 were identified. To evaluate the long‐term financial burden, patients surviving ≥ 3 years post‐resection were prospectively surveyed using the Comprehensive Score for financial Toxicity (COST‐FACIT) and a customized institutionally developed questionnaire. A logistic regression model predicting high financial toxicity was used to identify predictive factors. Results Among 238 eligible patients, 137 (57.6%) responded. Responders had a median age of 66 (59–73) years, with 86.7% identifying as financial prosperous or comfortable. However, 33.3% experienced financial distress due to treatment costs, 27.3% demonstrated high financial toxicity on the COST‐FACIT survey, and 37.2% made sacrifices to afford treatment. Only 8.9% stated that the treatment costs influenced their decisions, and the majority (85.9%) did not discuss financial implications with healthcare providers. Multivariable analysis identified younger age as a risk factor for high financial toxicity. Conclusion One in three long‐term survivors experienced high financial toxicity, with younger age being a predictor. This emphasizes the need for efforts to provide comprehensive support and guidance to patients to navigate their oncological journey.
Missense and loss‐of‐function variants at GWAS loci in familial Alzheimer's disease
Gunasekaran, Tamil Iniyan , Reyes‐Dumeyer, Dolly , Faber, Kelley , Goate, Alison , Pericak‐Vance, Margaret, Haines, Jonathan L. , Rosenberg, Roger N., Mejía, Diones Rivera , Medrano, Martin , Lantigua, Rafael , Alba, Camille , Mayeux, Richard , Bennett, David A. , Wilson, Robert S. , Bennett, David A. , Goate, Alison M , Boeve, Bradley F. , Cruchaga, Carlos , Pericak‐Vance, Margaret, Tsuang, Debby W. , Sweet, Robert A. , Soni, Rajesh K , Wilson, Robert S., Dalgard, Clifton L. , Foroud, Tatiana , Vardarajan, Badri Narayan

Alzheimer's & Dementia | September 5, 2024 | Volume: 20 | Issue: 11 | Pages: 7580-7594

10.1002/alz.14221 | PMID 39233587 Get It

Abstract BACKGROUND Few rare variants have been identified in genetic loci from genome‐wide association studies (GWAS) of Alzheimer's disease (AD), limiting understanding of mechanisms, risk assessment, and genetic counseling. METHODS Using genome sequencing data from 197 families in the National Institute on Aging Alzheimer's Disease Family Based Study and 214 Caribbean Hispanic families, we searched for rare coding variants within known GWAS loci from the largest published study. RESULTS Eighty‐six rare missense or loss‐of‐function (LoF) variants completely segregated in 17.5% of families, but in 91 (22.1%) families Apolipoprotein E ( APOE)‐ 𝜀4 was the only variant segregating. However, in 60.3% of families, APOE 𝜀4, missense, and LoF variants were not found within the GWAS loci. DISCUSSION Although APOE 𝜀4and several rare variants were found to segregate in both family datasets, many families had no variant accounting for their disease. This suggests that familial AD may be the result of unidentified rare variants. Highlights Rare coding variants from GWAS loci segregate in familial Alzheimer's disease. Missense or loss of function variants were found segregating in nearly 7% of families. APOE‐𝜀4 was the only segregating variant in 29.7% in familial Alzheimer's disease. In Hispanic and non‐Hispanic families, different variants were found in segregating genes. No coding variants were found segregating in many Hispanic and non‐Hispanic families.
Anatomic Characteristics of Eyes With Fuchs Endothelial Corneal Dystrophy
Miller, Darby D. , Wagner, Isabella V. , Hasan, Syed A. , Stewart, Michael W., Towne, Caleb M., Baratz, Keith H. , Li, Zhuo , Miller, Darby D , Wagner, Isabella V , Li, Zhuo

Cornea | September 5, 2024 | Volume: 44 | Issue: 3 | Pages: 311-323

10.1097/ico.0000000000003694 | PMID 39231632 Get It

Purpose: The purpose of this study was to evaluate and compare the anatomic characteristics of eyes with Fuchs endothelial corneal dystrophy (FECD) with eyes without FECD. Methods: This study was a retrospective chart review performed at an academic medical center. Patients with FECD were identified through a search of the electronic medical records. Eligible patients underwent Scheimpflug imaging and optical biometry and were compared with age and sex-matched control subjects who underwent similar testing in preparation for cataract surgery. Several measurements of the cornea, anterior chamber, and eyes were evaluated using multivariable linear regression models and multivariable logistic regression models. Results: A total of 404 eyes (202 eyes with FECD and 202 control eyes) were included in this study. Compared with controls, eyes with FECD had shallower AC depths, lower AC volumes, and narrower angles. Conversely, the spherical equivalent before cataract surgery, corneal pachymetry, and corneal volume were higher in eyes with FECD. On Scheimpflug imaging analysis, these anatomical differences were present in FECD eyes with and without corneal edema. After adjusting for sex, these differences remained statistically significant. Shorter axial length was found to be statistically significant in male eyes but not in female eyes with FECD. Conclusions: This study reports new ocular characteristics in FECD eyes with and without edema. Optical biometry and Scheimpflug imaging established that the anatomic findings in eyes with FECD were not simply due to the larger volume of an edematous cornea but rather unique to eyes with FECD. These findings will provide reliable, normative data for future studies examining surgical, medical, and anatomical factors in FECD.
Leiomyosarcomas of the Visceral Adnexal and Uterine Ligaments and Adnexal Connective Tissue: Immunohistochemical, Molecular Genetic, and MDM2 Fluorescence In Situ Hybridization Analysis
Dashti, Nooshin K. , Swanson, Amy A. , Patel, Vatsal, Xing, Deyin , Feely, Michael, Keeney, Gary L., Gupta, Sounak , Schoolmeester, J. Kenneth

International Journal of Gynecological Pathology | September 4, 2024 | Volume: 44 | Issue: 4 | Pages: 355-357

10.1097/pgp.0000000000001064 | PMID 39230557 Get It

Longitudinal Impact of Dobbs v Jackson Women’s Health Organization on Abortion Service Delivery in Ohio, 2022‒2023
Smith, Mikaela H. , McGowan, Michelle L. , Kerestes, Courtney , Norris, Alison, Bessett, Danielle , Norris, Alison H. , Smith, Mikaela H.

American Journal of Public Health | September 4, 2024 | Volume: 114 | Issue: 10 | Pages: 1034-1042

10.2105/ajph.2024.307775 | PMID 39231404 Get It

Objectives. To assess the impact of Ohio’s abortion policy changes on abortion provision following Dobbs v Jackson Women’s Health Organization. Methods. We analyzed quantitative and write-in responses from an ongoing survey of 6 abortion facilities in Ohio for 3 time periods: January‒June 2022 (pre- Dobbs), July‒September 2022 (6-week ban in effect), and October 2022‒June 2023 (post- Dobbs, ban blocked). We disaggregated counts by method, gestation, and state of residence. Results. Following Dobbs, Ohio banned abortions after detection of embryonic cardiac activity, and monthly abortion provision decreased 56%. Several months after the ban was lifted, monthly abortion means exceeded pre- Dobbs means. The percentage of patients from out of state increased over time. Conclusions. The post- Dobbs enactment of a restrictive abortion ban drastically reduced availability of reproductive health care in Ohio. Nevertheless, Ohio remained an important destination for patients from surrounding states with abortion restrictions. Public Health Implications. Gestational bans decrease access to necessary health care; instead, states like Ohio should work to eliminate barriers to abortion care to support the health and well-being of people in their own and surrounding states. ( Am J Public Health. 2024;114(10):1034–1042. https://doi.org/10.2105/AJPH.2024.307775 )
Assessment of the Addition of Oxaliplatin to Fluoropyrimidine-Based Adjuvant Chemotherapy in Patients With High-Risk Stage II Colon Cancer: An ACCENT Pooled Analysis
Chibaudel, Benoist , Raeisi, Morteza , Cohen, Romain , Yothers, Greg , Goldberg, Richard M. , Wolmark, Norman , Yoshino, Takayuki , Schmoll, Hans‐Joachim , George, Thomas J. , Shacham‐Shmueli, Einat , Gramont, Aimery de , Wolmark, Norman , Yoshino, Takayuki , Schmoll, Hans-Joachim , George, Thomas J , Shi, Qian , André, Thierry , De Gramont, Aimery , Yothers, Greg , Chibaudel, Benoist , Cohen, Romain , Bachet, Jean‐Baptiste , Kerr, Rachel , Lonardi, Sara , Shi, Qian , André, Thierry

Journal of Clinical Oncology | September 4, 2024 | Volume: 42 | Issue: 35 | Pages: 4187-4195

10.1200/jco.24.00394 | PMID 39231393 Get It

PURPOSE The adjuvant treatment for stage III colon cancer (CC) is chemotherapy combining fluoropyrimidine (FP) and oxaliplatin (OX). FP regimen plus OX (FPOX) may benefit in high-risk stage II CC. We performed a pooled analysis of pivotal MOSAIC and C-07 studies evaluating FPOX for the treatment of high-risk stage II CC according to prognostic factors, number of high-risk factors, and current clinicopathologic risk classification on the basis of T stage, tumor perforation, and number of lymph nodes examined. PATIENTS AND METHODS One thousand five hundred and ninety-five patients with stage II CC receiving FP or FPOX were pooled. The overall survival (OS) benefit of OX was analyzed using Kaplan-Meier curves and unadjusted Cox models stratified by study. Three thousand and fifty-nine patients with stage III CC were used only for interaction tests between the allocated chemotherapy and stage. RESULTS In the pooled analysis of stage II patients, independent prognostic factors in multivariable analysis were sex, age, perforation/obstruction, and tumor sidedness. There was a significant interaction in OS between stage and allocated chemotherapy with hazard ratios (HRs) of 1.03 for stage II (95% CI, 0.82 to 1.29; P = .813) and 0.82 for stage III (95% CI, 0.73 to 0.92; P = .001; P int = .073). There was no benefit from the addition of OX to FP for any of the prognostic factors. The number of high-risk factors tested was not predictive of OX benefit. According to the currently agreed clinicopathologic risk classification, no OS benefit of OX was observed, as HR was 0.86 (95% CI, 0.63 to 1.18; P = .349). CONCLUSION No OS benefit of adjuvant OX was found in high-risk stage II CC, regardless of the definition used to characterize tumors as having a high risk for recurrence. Hence, our analysis suggests that OX should not be the standard of care for adjuvant chemotherapy for stage II CC, even in high-risk patients.